Clinical Trial Update: Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a cancer vaccine, trastuzumab, and vinorelbine in women with locally recurrent or metastatic breast cancer; the study was terminated, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)
• cancer vaccine (cancer vaccine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-09